Amgen (AMGN) Stock

The Dow Jones Industrial Average includes 30 carefully selected companies that have been leaders in their fields at some point. Currently, the three Dow stocks with the highest yields are Verizon Communications, Chevron, and Amgen. Verizon is among the biggest telecommunications companies in the U.S.

Amgen (AMGN) has recently caught the attention of Zacks.com users. Therefore, it's important to look into what the future holds for this stock.

In the fourth quarter of 2024, Amgen's stock price took a significant downturn because its weight loss drug did not generate much interest. After reaching a high of $341 in July, the stock dropped more than 25% to its current value of $260.

In the most recent trading session, Amgen (AMGN) finished at $260.64, which is an increase of 0.52% compared to the previous day.

In the most recent trading session, Amgen (AMGN) finished at $259.30, which is a decrease of 1.28% compared to the previous day.

On the most recent trading day, Amgen (AMGN) closed at $264, which is an increase of 0.24% compared to its last closing price.

Lately, users of Zacks.com have been focusing on Amgen (AMGN). This interest prompts a closer look at what the stock might offer.

On Friday, Novo Nordisk A/S NVO announced the main results from the REDEFINE 1 Phase 3 trial, which is part of the global REDEFINE program.

We have just put together a list of the 10 Dogs of the Dow Dividend Stocks to consider for investment. In this article, we will examine how Amgen Inc. (NASDAQ:AMGN) compares to other dividend stocks. Investors who focus on dividends usually prefer stocks with high yields and base their strategies on these types of investments.